ID

25935

Description

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00437060

Lien

https://clinicaltrials.gov/show/NCT00437060

Mots-clés

Versions (1)
  1. 27/09/2017 27/09/2017 -
Téléchargé le

27 septembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility B-cell Childhood Acute Lymphoblastic Leukemia NCT00437060

Anglais

Eligibility B-cell Childhood Acute Lymphoblastic Leukemia NCT00437060

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of acute lymphoblastic leukemia
Description

Acute lymphocytic leukemia

Type de données

boolean

Alias
UMLS CUI [1]
C0023449
enrolled on cog-aall0434 (cohort #1 only) or cog-aall0232 (cohorts #1 and #2)
Description

Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
patients must have received either high-dose methotrexate or escalating-dose methotrexate during interim maintenance.
Description

Methotrexate High dose | Methotrexate Dose Increasing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0444956
UMLS CUI [2,1]
C0025677
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0442808
no cns-3 disease
Description

CNS3 Disease Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C3899748
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C2828389
patients must enroll within 8-24 months after completion of therapy on cog-aall0232 and no evidence of relapsed or secondary malignancy
Description

Study Subject Participation Status | Recurrent Malignant Neoplasm Absent | Secondary Malignant Neoplasm Absent

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C1458156
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C3266877
UMLS CUI [3,2]
C0332197
no known significant neurodevelopmental disability unrelated to cancer diagnosis including, but not limited to, any of the following:
Description

Neurodevelopmental Disorders Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C1535926
UMLS CUI [1,2]
C2828389
down syndrome
Description

Down Syndrome Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013080
UMLS CUI [1,2]
C2828389
fragile x mental retardation
Description

Fragile X Syndrome Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C0016667
UMLS CUI [1,2]
C2828389
autism
Description

Autistic Disorder Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004352
UMLS CUI [1,2]
C2828389
pervasive developmental disability
Description

Pervasive Development Disorder Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C0524528
UMLS CUI [1,2]
C2828389
seizure disorder
Description

Epilepsy Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C0014544
UMLS CUI [1,2]
C2828389
attention-deficit hyperactivity disorder or specific learning disability (e.g., dyslexia) allowed
Description

Attention deficit hyperactivity disorder | Learning Disability Specific | Dyslexia

Type de données

boolean

Alias
UMLS CUI [1]
C1263846
UMLS CUI [2,1]
C0751265
UMLS CUI [2,2]
C0205369
UMLS CUI [3]
C0476254
no sensory impairment (e.g., pre-existing uncorrectable vision impairment or deafness)
Description

Hypesthesia Excluded | Visual Impairment uncorrected Pre-existing Exclusion | Deafness Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020580
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C3665347
UMLS CUI [2,2]
C4072785
UMLS CUI [2,3]
C2347662
UMLS CUI [2,4]
C2828389
UMLS CUI [3,1]
C0011053
UMLS CUI [3,2]
C2828389
no cranial radiation therapy
Description

Therapeutic radiology procedure cranial Exclusion

Type de données

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0037303
UMLS CUI [1,3]
C2828389
Retour au début de la page

Similar models

Eligibility B-cell Childhood Acute Lymphoblastic Leukemia NCT00437060

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Acute lymphocytic leukemia
Item
diagnosis of acute lymphoblastic leukemia
boolean
C0023449 (UMLS CUI [1])
Study Subject Participation Status
Item
enrolled on cog-aall0434 (cohort #1 only) or cog-aall0232 (cohorts #1 and #2)
boolean
C2348568 (UMLS CUI [1])
Methotrexate High dose | Methotrexate Dose Increasing
Item
patients must have received either high-dose methotrexate or escalating-dose methotrexate during interim maintenance.
boolean
C0025677 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0025677 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0442808 (UMLS CUI [2,3])
CNS3 Disease Excluded
Item
no cns-3 disease
boolean
C3899748 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
Study Subject Participation Status | Recurrent Malignant Neoplasm Absent | Secondary Malignant Neoplasm Absent
Item
patients must enroll within 8-24 months after completion of therapy on cog-aall0232 and no evidence of relapsed or secondary malignancy
boolean
C2348568 (UMLS CUI [1])
C1458156 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C3266877 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Neurodevelopmental Disorders Excluded
Item
no known significant neurodevelopmental disability unrelated to cancer diagnosis including, but not limited to, any of the following:
boolean
C1535926 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Down Syndrome Excluded
Item
down syndrome
boolean
C0013080 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Fragile X Syndrome Excluded
Item
fragile x mental retardation
boolean
C0016667 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Autistic Disorder Excluded
Item
autism
boolean
C0004352 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Pervasive Development Disorder Excluded
Item
pervasive developmental disability
boolean
C0524528 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Epilepsy Excluded
Item
seizure disorder
boolean
C0014544 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Attention deficit hyperactivity disorder | Learning Disability Specific | Dyslexia
Item
attention-deficit hyperactivity disorder or specific learning disability (e.g., dyslexia) allowed
boolean
C1263846 (UMLS CUI [1])
C0751265 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
C0476254 (UMLS CUI [3])
Hypesthesia Excluded | Visual Impairment uncorrected Pre-existing Exclusion | Deafness Excluded
Item
no sensory impairment (e.g., pre-existing uncorrectable vision impairment or deafness)
boolean
C0020580 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C3665347 (UMLS CUI [2,1])
C4072785 (UMLS CUI [2,2])
C2347662 (UMLS CUI [2,3])
C2828389 (UMLS CUI [2,4])
C0011053 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
Therapeutic radiology procedure cranial Exclusion
Item
no cranial radiation therapy
boolean
C1522449 (UMLS CUI [1,1])
C0037303 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial